Inspiratory Muscle Rehabilitation in Children With Obesity

Pediatric Obesity Clinical Trial

— BREATHE Fit  

Official title:

Inspiratory Muscle Rehabilitation in Children With Obesity to Promote Physical Activity

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05412134
• Other study ID #: Pro00110494
• Status: Completed
• Phase: N/A
• Start date: August 23, 2022
• Est. completion date: March 3, 2023

Study information

• Verified date: April 2024
• Source: Duke University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This is a single-center, randomized, SHAM-controlled, parallel assignment, double-masked, interventional trial among children aged 8-17 years (not yet 18 years old) of age with obesity (n=30), recruited from the Duke Healthy Lifestyles Clinic to test the effectiveness of inspiratory muscle rehabilitation (IMR) as an acceptable add-on intervention to reduce dyspnea (feeling short-of-breath or breathless) and to promote greater activity in children with obesity

Description:

Improved management of obesity is an urgent public health need. Nearly 40% of US children and adolescents have a body mass index that markedly increases their risk for serious metabolic and cardiopulmonary sequelae. Current childhood obesity rates, for the first time in US history, predict a decline in life US expectancy. Importantly, childhood obesity is a key driver of health disparities in the US, with obesity disproportionately affecting African-American, Hispanic-Latino, and Native American children. A key contributor to the sequelae of obesity is sedentariness. Thus, best practice in obesity management includes both reducing sedentariness and establishing durable increases in daily physical activity, however, attrition from planned exercise programs remains high. A key challenge to initiating and sustaining physical activity in children with obesity is the extreme dyspnea (breathlessness) they experience. This is due to the altered thoracic mechanics of obesity which lead to enhanced inspiratory muscle fatigue and dyspnea, with even modest physical activity. Our group has confirmed that among adolescents, higher body mass index (BMI) associates with lower inspiratory muscle endurance (r= -0.680, p=0.049, n=14), and that this lower endurance correlates with more frequent dyspnea (r= - 0.672, p=0.023, n=12). Treating obesity-related inspiratory muscle impairment and dyspnea is a promising approach to support physical activity in children with obesity but is yet unproven.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 27
• Est. completion date: March 3, 2023
• Est. primary completion date: February 28, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 8 Years to 17 Years

Eligibility

Inclusion Criteria:

• Documented informed consent from legal guardian and assent from participant as appropriate.

• Children 8 to 17 years of age with obesity (BMI = 95th percentile for age and sex) being seen at Duke Healthy Lifestyles clinic.

• Participants (or parent/guardian) must have access to the internet and an approved smart device/computer.

• Child must have a designated caregiver who expresses a commitment to encourage the participant to complete the study procedures.

• Participant and legal guardian must speak and read English.

Exclusion Criteria:

• Prior enrollment in an IMR program.

• Contraindications for IMR including a history of recent lung surgery, recent pulmonary embolism, or history of recurrent spontaneous pneumothorax

• Progressive neurological or neuromuscular disorders or need for chronic O2 therapy.

• Inability to complete baseline measurements in a satisfactory manner according to the judgment of the research coordinator or PI.

• Current self-reported pregnancy or planning to become pregnant.

• Body weight greater than 300 pounds.

• Any condition in the opinion of the PI that would not allow safe conduct of study procedures (including IMR, MIP testing or step-test), such as a physical disability, recent musculoskeletal injury or illness, current and ongoing evaluation for undiagnosed cardiopulmonary or neurologic symptoms, undiagnosed chest pain, pneumothorax in the past 12 months, inner ear surgery in the past 12 months, or undiagnosed syncopal episodes.

Related Conditions & MeSH terms

• Obesity
• Pediatric Obesity

Intervention

Device:
• Pro2 - 75% of participant's MIP
Each participant will be provided a PrO2™ device and trained on its use as well as its accompanying PrO2 Fit™ app. The PrO2™ is a flow-resistive device that provides inspiratory resistance via a fixed 2mm orifice and has Bluetooth connectivity to most IOS/Android devices or Mac/Windows computers. The PrO2™ device and app allows for both 100% adherence monitoring and immediate user biofeedback. Participants will be instructed to inspire forcefully through PrO2™ until the device signals that the user has achieved the target resistance (via audible alarm and visible light signal). The research team will implement biofeedback signals at a specific inspiratory resistance to provide precise and individualized training target. Successful IMR repetitions will require that subjects achieve a pressure target that is 75% of their MIP.
• Pro2 - 15% of participant's MIP
Participants in the control intervention will also use the same PrO2™ device but at a reduced peak resistance of 15% MIP. The research team will implement biofeedback signals at a specific inspiratory resistance to provide precise and individualized training target. Successful IMR repetitions will require that subjects achieve a pressure target that is 15% of their MIP for each repetition. Participants will perform 3 sets of 50 inspiratory breaths 3 times per week.

Locations

Country	Name	City	State
United States	Duke Healthy Lifestyles Clinic	Durham	North Carolina

Sponsors (2)

Lead Sponsor	Collaborator
Duke University	The Derfner Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Heart Rate Change During 3-minute Step Test (HRC)	determined by the change in HRC from baseline to final visit after intervention	Baseline, approximately 2 months
Primary	Number of Participants Who Complete Study Visit 3		approximately 2 months
Primary	Adherence to Active IMR (Inspiratory Muscle Rehabilitation)	Percentage of IMR completion (actual / planned reps over intervention period x 100)	up to 2 months
Primary	Participant Satisfaction With IMR (Inspiratory Muscle Rehabilitation)	Scored on a 5-point Likert scale where 1 = strongly disagree, 2 = disagree, 3 = neutral, 4 = agree, 5 = strongly agree.	up to 2 months
Secondary	Change in Maximum Inspiratory Pressure (MIP) Over Intervention Period		Baseline, approximately 2 months
Secondary	Change in Modified Medical Research Council (mMRC) Dyspnea Scores Over Intervention Period	The mMRC scale is a self-rating tool to measure the degree of disability that breathlessness poses on day-to-day activities on a scale from 0 to 4: 0, no breathlessness except on strenuous exercise; 1, shortness of breath when hurrying on the level or walking up a slight hill; 2, walks slower than people of same age on the level because of breathlessness or has to stop to catch breath when walking at their own pace on the level; 3, stops for breath after walking ~100 m or after few minutes on the level; and 4, too breathless to leave the house, or breathless when dressing or undressing.	Baseline, approximately 2 months
Secondary	Change in Average Daily Moderate-vigorous Physical Activity (MVPA) Time		Baseline, approximately 2 months
Secondary	Change in Average Daily Sedentary Physical Activity (SPA) Time	Determined by the difference in MVPA between the baseline (run-in) value and value taken at the end of the intervention period.	Baseline, approximately 2 months
Secondary	Change in Average Daily Step Count		Baseline, approximately 2 months